Ensign Peak Advisors’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,350
| Closed | -$11K | – | 2311 |
|
|
2022
Q2 | $11K | Sell |
1,350
-126,082
| -99% | -$1.03M | ﹤0.01% | 2143 |
|
|
2022
Q1 | $2.15M | Hold |
127,432
| – | – | ﹤0.01% | 852 |
|
|
2021
Q4 | $2.74M | Sell |
127,432
-218,052
| -63% | -$4.69M | 0.01% | 849 |
|
|
2021
Q3 | $25.5M | Sell |
345,484
-31,381
| -8% | -$2.32M | 0.05% | 275 |
|
|
2021
Q2 | $20.6M | Buy |
376,865
+40,566
| +12% | +$2.22M | 0.04% | 313 |
|
|
2021
Q1 | $24.8M | Buy |
336,299
+309,255
| +1,144% | +$22.8M | 0.05% | 276 |
|
|
2020
Q4 | $2.33M | Buy |
+27,044
| New | +$2.33M | 0.01% | 972 |
|